BiotechTube
Home/Caliway Biopharmaceuticals/W. Timothy Garvey, MD
WT

W. Timothy Garvey, MD

Scientific Advisor

Caliway Biopharmaceuticals

Therapeutic Areas

Aesthetic MedicineMetabolic DiseaseDermatologyRheumatology

Caliway Biopharmaceuticals Pipeline

DrugIndicationPhase
CBL-514Non-surgical Localized Fat ReductionPhase 3 (Preparatory)
CBL-0206Localized Fat Reduction (Asia-Pacific)Phase 2 (Planned)
CBA-539Hyperpigmentation, Skin Brightening, Anti-agingDiscovery/Preclinical
CBF-520Central Obesity / Visceral Fat ReductionDiscovery/Preclinical
Unnamed Joint InjectionOsteoarthritisDiscovery/Preclinical

Leadership Team at Caliway Biopharmaceuticals

AM
Arya M. Sharma, MD
Scientific Advisor
View full Caliway Biopharmaceuticals profile